Title : Prospective study of everolimus with calcineurin inhibitor-free immunosuppression after heart transplantation: results at four years.

Pub. Date : 2014 Mar

PMID : 24206966






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prospective study of everolimus with calcineurin inhibitor-free immunosuppression after heart transplantation: results at four years. Everolimus calcineurin binding protein 1 Homo sapiens
2 Few studies have examined everolimus therapy with calcineurin inhibitor (CNI) withdrawal in maintenance heart transplant patients (HTx). Everolimus calcineurin binding protein 1 Homo sapiens
3 Few studies have examined everolimus therapy with calcineurin inhibitor (CNI) withdrawal in maintenance heart transplant patients (HTx). Everolimus calcineurin binding protein 1 Homo sapiens
4 CONCLUSIONS: Calcineurin inhibitor-free immunosuppression with everolimus is an effective and safe option in selected maintenance HTx patients. Everolimus calcineurin binding protein 1 Homo sapiens